Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle
- 17 March 2005
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 12 (9) , 762-771
- https://doi.org/10.1038/sj.gt.3302481
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial DiseaseCirculation, 2003
- Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trialVascular Medicine, 2003
- Angiogenesis of the heartMicroscopy Research and Technique, 2003
- Therapeutic angiogenesis: a complex problem requiring a sophisticated approach.Cardiovascular Toxicology, 2003
- Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZThe Journal of Gene Medicine, 2002
- Adenovirus-Mediated Gene Transfer of VEGF 121 Improves Lower-Extremity Endothelial Function and Flow ReserveCirculation, 2001
- Therapeutic Angiogenesis: A Case for Targeted, Regulated Gene DeliveryCritical Reviews™ in Eukaryotic Gene Expression, 2000
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJournal of Clinical Investigation, 1999
- Critical Limb Ischemia: Nothing To Give at the Office?Annals of Internal Medicine, 1999
- Direct Intramuscular Injection of Plasmid DNA Encoding Angiopoietin-1 but not Angiopoietin-2 Augments Revascularization in the Rabbit Ischemic HindlimbCirculation, 1998